Striatal Excitatory Amino Acid Transporter Transcript Expression in Schizophrenia, Bipolar Disorder, and Major Depressive Disorder

Neuropsychopharmacology

Volumn 26, Issue 3, 2002, Pages 368-375

  McCullumsmith, Robert E ^a   Meador Woodruff, James H ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Affective disorder; Antidepressant; Glutamate; Mood disorder; Mood stabilizer; Striatum

Indexed keywords

EXCITATORY AMINO ACID RECEPTOR; EXCITATORY AMINO ACID TRANSPORTER 1; EXCITATORY AMINO ACID TRANSPORTER 2; EXCITATORY AMINO ACID TRANSPORTER 3; EXCITATORY AMINO ACID TRANSPORTER 4; GLUTAMATE RECEPTOR; MESSENGER RNA; UNCLASSIFIED DRUG;

ADULT; AGED; AMINO ACID TRANSPORT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DEPRESSION; FEMALE; GLIA; HUMAN; HUMAN TISSUE; HUNTINGTON CHOREA; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; MALE; MANIC DEPRESSIVE PSYCHOSIS; NERVE CELL; NEUROTRANSMISSION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHIZOPHRENIA;

ADULT; AGED; AMINO ACID TRANSPORT SYSTEM X-AG; ANALYSIS OF VARIANCE; BIPOLAR DISORDER; CARRIER PROTEINS; CORPUS STRIATUM; DEPRESSIVE DISORDER, MAJOR; EXCITATORY AMINO ACID TRANSPORTER 1; EXCITATORY AMINO ACID TRANSPORTER 2; EXCITATORY AMINO ACID TRANSPORTER 3; EXCITATORY AMINO ACID TRANSPORTER 4; FEMALE; GENE EXPRESSION PROFILING; GLUTAMATE PLASMA MEMBRANE TRANSPORT PROTEINS; HUMANS; MALE; MIDDLE AGED; RECEPTORS, GLUTAMATE; RNA, MESSENGER; SCHIZOPHRENIA; SYMPORTERS;

EID: 0036176676     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(01)00370-0     Document Type: Article

References (61)

1. Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics
2. Increased density of glutamate/N-methyl-D-aspartate receptors in putamen from schizophrenic patients
3. Cloning and expression of a human neutral amino acid transporter with structural similarity to the glutamate transporter gene family
4. Excitatory amino acid transporter 5, a retinal glutamate transporter coupled to a chloride conductance
5. Changes of NMDA receptor subunit (NR1, NR2B) and glutamate transporter (GLT1) mRNA expression in Huntington's disease - An in situ hybridization study
6. Reduced glutamate in the anterior cingulate cortex in depression: An in vivo proton magnetic resonance spectroscopy study
7. Distribution of glutamate transporter subtypes during human brain development
8. Antidepressant effects of ketamine in depressed patients
9. Proton MR spectroscopy in children with bipolar affective disorder: Preliminary observations
10. Glutamate transporters in glial plasma membranes: Highly differentiated localizations revealed by quantitative ultrastructural immunocytochemistry
11. Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia
12. Chronic haloperidol treatment impairs glutamate transport in the rat striatum
13. The antibipolar drug valproate mimics lithium in stimulating glutamate release and inositol 1,4,5-trisphosphate accumulation in brain cortex slices but not accumulation of inositol monophosphates and bisphosphates
14. Lithium acutely inhibits and chronically up-regulates and stabilizes glutamate uptake by presynaptic nerve endings in mouse cerebral cortex
15. Decreased expression of mRNAs encoding non-NMDA glutamate receptors GluR1 and GluR2 in medial temporal lobe neurons in schizophrenia
16. GluR2 glutamate receptor subunit flip and flop isoforms are decreased in the hippocampal formation in schizophrenia: A reverse transcriptase-polymerase chain reaction (RT-PCR) study
17. Immunoautoradiographic evidence for a loss of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate-preferring non-N-methyl-D-aspartate glutamate receptors within the medial temporal lobe in schizophrenia
18. The expression of the glial glutamate transporter protein EAAT2 in motor neuron disease: An immunohistochemical study
19. Cellular and synaptic localization of the neuronal glutamate transporters excitatory amino acid transporter 3 and 4
20. Characterization of the human glutamate receptor subunit 3 gene (GRIA3), a candidate for bipolar disorder and nonspecific X-linked mental retardation
21. NR2B-containing NMDA receptors are up-regulated in temporal cortex in schizophrenia
22. Decreased hippocampal expression of a glutamate receptor gene in schizophrenia
23. AMPA receptor binding and subunit mRNA expression in prefrontal cortex and striatum of elderly schizophrenics
24. NMDA receptor mRNA correlation with antemortem cognitive impairment in schizophrenia
25. Ionotropic glutamate receptor binding and subunit mRNA expression in thalamic nuclei in schizophrenia
26. Asymmetrical loss of glutamate receptor subtype in left hippocampus in schizophrenia
27. Quantitative autoradiographic analysis of glutamate binding sites in the hippocampal formation in normal and schizophrenic brain post mortem
28. [3]MK-801 binding sites in postmortem brain regions of schizophrenic patients
29. Differential expression of two glial glutamate transporters in the rat brain: Quantitative and immunocytochemical observations
30. Increased cerebrospinal fluid glutamine levels in depressed patients
31. Aberrant RNA processing in a neurodegenerative disease: The cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis
32. Glutamate receptor expression in schizophrenic brain
33. Effects of cocaine on dopamine receptor gene expression: A study in the postmortem human brain
34. Dopamine receptor gene expression in the human medial temporal lobe
35. Striatal ionotropic glutamate receptor expression in schizophrenia, bipolar disorder, and major depressive disorder
36. The expression of glutamate transporter GLT-1 in the rat cerebral cortex is down-regulated by the antipsychotic drug clozapine
37. The EAAT2 (GLT-1) gene in motor neuron disease: Absence of mutations in amyotrophic lateral sclerosis and a point mutation in patients with hereditary spastic paraplegia
38. The RNA of the glutamate transporter EAAT2 is variably spliced in amyotrophic lateral sclerosis and normal individuals
39. Expression of the glial glutamate transporter EAAT2 in the human CNS: An immunohistochemical study
40. Increased [3H]kainic acid binding in the prefrontal cortex in schizophrenia
41. Glutamate receptors in the postmortem striatum of schizophrenic, suicide, and control brains
42. Adaptive changes in the N-methyl-D-aspartate receptor complex after chronic treatment with imipramine and 1-aminocyclopropanecarboxylic acid
43. Expression of the human excitatory amino acid transporter 2 and metabotropic glutamate receptors 3 and 5 in the prefrontal cortex from normal individuals and patients with schizophrenia
44. Distribution of kainate receptor subunit mRNAs in human hippocampus, neocortex and cerebellum, and bilateral reduction of hippocampal GluR6 and KA2 transcripts in schizophrenia
45. Localization of neuronal and glial glutamate transporters
46. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate
47. Chronic neuroleptic treatment alters expression of glial glutamate transporter GLT-1 mRNA in the striatum
48. Expression patterns and regulation of glutamate transporters in the developing and adult nervous system
49. Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment: Implications for the pharmacotherapy of depression
50. Expression of excitatory amino acid transporter transcripts in the thalamus in schizophrenia
51. Expression of NMDAR1, GluR1, GluR7, and KA1 glutamate receptor mRNAs is decreased in frontal cortex of "neuroleptic-free" schizophrenics: Evidence on reversible up-regulation by typical neuroleptics
52. Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1
53. The Stanley foundation brain collection and neuropathology consortium
54. Functional antagonists at the NMDA receptor complex exhibit antidepressant actions
55. 1-Aminocyclopropanecarboxylates exhibit antidepressant and anxiolytic actions in animal models
56. Cloning and functional characterization of a system ASC-like Na+-dependent neutral amino acid transporter
57. Glycine site antagonists and partial agonists inhibit N-methyl-D-aspartate receptor-mediated [3H]arachidonic acid release in cerebellar granule cells
58. Motor discoordination and increased susceptibility to cerebellar injury in GLAST mutant mice
59. Rat pup isolation calls are reduced by functional antagonists of the NMDA receptor complex
60. EAAT4 is a post-synaptic glutamate transporter at Purkinje cell synapses
61. Changes in expression and distribution of the glutamate transporter EAAT4 in developing mouse Purkinje cells